Constellation Brands Operating Cash Flow decreased by 8.8% to $562.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.4%, from $594.70M to $562.80M. Over 4 years (FY 2022 to FY 2026), Operating Cash Flow shows relatively stable performance with a -0.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $716.00M | $809.90M | $918.20M | $261.30M | $758.20M | $896.10M | $626.30M | $476.30M | $665.40M | $956.60M | $724.80M | $433.20M | $690.50M | $1.18B | $685.20M | $594.70M | $637.20M | $852.10M | $616.90M | $562.80M |
| QoQ Change | — | +13.1% | +13.4% | -71.5% | +190.2% | +18.2% | -30.1% | -24.0% | +39.7% | +43.8% | -24.2% | -40.2% | +59.4% | +71.2% | -42.0% | -13.2% | +7.1% | +33.7% | -27.6% | -8.8% |
| YoY Change | — | — | — | — | +5.9% | +10.6% | -31.8% | +82.3% | -12.2% | +6.8% | +15.7% | -9.0% | +3.8% | +23.5% | -5.5% | +37.3% | -7.7% | -27.9% | -10.0% | -5.4% |